ReviewPharmaceuticals (Basel, Switzerland)2022

Continuous Subcutaneous Insulin Infusion (CSII) Combined with Oral Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis of Randomized, Controlled Trials.

Hui Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.